Shree Ganesh Bio-Tech Intrinsic Value
Shree Ganesh Bio-Tech intrinsic value. Shree Ganesh Bio-Tech (SHREEGANES) median intrinsic value is ₹1.17 from 3 valuation models (range ₹1–₹1), vs current price ₹0.47 — +148.9% upside (Trading Below Calculated Value), margin of safety 59.8%. Compare with SHREEGANES DCF valuation to assess whether the stock is under or overvalued.
SHREEGANES Valuation Methods Summary — DCF, Graham Number & P/E
Shree Ganesh Bio-Tech intrinsic value across 3 models vs current price ₹0.47 — upside/downside and value range per method. Read SHREEGANES dividend payout details for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹1.17 | ₹1.05 - ₹1.29 | +148.9% | Book Value/Share: ₹16.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹0.94 | ₹0.85 - ₹1.03 | +100.0% | Revenue/Share: ₹1.75, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹1.17 | ₹0.94 - ₹1.40 | +148.9% | CF Growth: 15.0%, Discount: 15% |
SHREEGANES Intrinsic Value vs Market Price — All Valuation Models
Shree Ganesh Bio-Tech fair value range ₹1–₹1 vs current market price ₹0.47 across 3 valuation models. For current market price and key ratios, visit SHREEGANES share price.
SHREEGANES Intrinsic Value Analysis — Undervalued or Overvalued?
Shree Ganesh Bio-Tech median intrinsic value ₹1.17, current price ₹0.47 — Trading Below Calculated Value by 148.9%, margin of safety 59.8%.
What is the intrinsic value of SHREEGANES?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Shree Ganesh Bio-Tech (SHREEGANES) is ₹1.17 (median value). With the current market price of ₹0.47, this represents a +148.9% variance from our estimated fair value.
The valuation range spans from ₹0.94 to ₹1.17, indicating ₹0.94 - ₹1.17.
Is SHREEGANES undervalued or overvalued?
Based on our multi-method analysis, Shree Ganesh Bio-Tech (SHREEGANES) appears to be trading below calculated value by approximately 148.9%.
SHREEGANES Financial Health — Key Ratios vs Industry Benchmarks
Shree Ganesh Bio-Tech financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | -1.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -35.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.11x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
SHREEGANES Cash Flow Quality — Operating & Free Cash Flow
Shree Ganesh Bio-Tech operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹-8 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹-10 Cr | ₹-10 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹10 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹11 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |